METabolic Explorer yesterday published its financial information for the 1st quarter of 2023. At the end of March 2023, the Group's consolidated sales amounted to 32.2 ME, including 19.9 ME from sales of specialty products and 12.3 ME from sales of commodities.

The level of sales for the 1st quarter of 2023 "is in line with the production reorganization measures implemented at the end of the 2022 financial year", says the company.

Compared with sales for the fourth quarter of 2022, the specialties business grew by 3 ME, with volumes up +16%. In this 1st quarter of activity, specialty sales accounted for 62% of Group sales.

Sales of commodities were down by 13 ME compared with the fourth quarter of 2022, representing a 50% drop in volumes sold. In this segment, METEX's business was impacted by pressure on prices and a delayed economic recovery in China.

The Group would like to point out that the securing of its financing plan has enabled it to undertake the investments planned in its transformation plan during the first quarter of 2023. As a reminder, these investments should enable the Group to reinforce its specialty amino acid production capacities and improve its energy performance.

Copyright (c) 2023 CercleFinance.com. All rights reserved.